Peterson & Co. acts for Revive Therapeutics Ltd. in Rights Offering
On May 16, 2016, Revive Therapeutics Ltd. (TSXV: RVV) announced a best efforts rights offering to raise $2.2 million. Revive is focused on commercializing treatments for gout, and rare diseases such as cystinuria, Wilson’s disease and Rett syndrome.
Peterson McVicar Acts for Red Cloud in Upsize of Fission 3.0 Brokered Private Placement to up to C$7.5 Million
Peterson McVicar acts for Bitfarms as it Acquires 24 Megawatts of Hydro Power in the U.S. and Enters into Memorandum of Understanding to Expand Up to 99 MW